Lexicon Inc., Little Rock, Ark., has promoted Angela Mitchell to director of production control and material management and Chadd Harper to director of production scheduling and programming, both ...

Lexicon Pharmaceuticals shares were 21% lower, at $1.14, after the company priced its underwritten public offering of 32 million shares at $1.30 a share. All of the shares are being offered by Lexicon ...

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) is one of the best fast growing penny stocks to buy according to analysts. On ...

Investing.com -- Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock fell 14.9% Friday after the company announced the pricing of ...

Lexicon Pharma (LXRX) prices 32M-share offering at $1.30 and $41M+ private placement to fund R&D and working capital—get the key details now.

The company also stands to gain from recent regulatory FDA guidance aimed at streamlining the development of non-opioid ...

As of Friday, January 30, Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 16.32%, which has investors ...

In addition to the shares being sold in the underwritten public offering, Lexicon has agreed to sell, in a concurrent private placement for expected aggregate gross proceeds of approximately $41.1 ...

Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.

“It's a wonderful morning for Lexicon, our scientists, clinicians and the patients and principal investigators,” summed up CEO and Director Lonnel Coats, as the biotech reported results from a phase 2 ...

Lexicon Inc., a Little Rock-based construction management and steel fabrication company, said Thursday it has become a ...

The Lexicon family of companies provides services including construction management, steel fabrication, erection, mechanical ...